Trial intelligence / Profile preview

TDT 067 in Distal Subungual Toenail Onychomycosis

NCT01145807Phase 3Unknown

Sponsor
Celtic Pharma
Start
Apr 2010
Primary completion
Feb 2012
Countries
1
01

Overview

A Phase 3 trial of TDT-067 in onychomycosis, sponsored by Celtic Pharma. Status: unknown.

02

Drugs

TDT-067
03

Conditions

onychomycosis

Beyond the preview

Go deeper on NCT01145807.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01145807.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call